Company Filing History:
Years Active: 2025
Title: Innovations by Laura S. Dellal in Drug Dosing Technology
Introduction
Laura S. Dellal is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of drug dosing technology, holding 2 patents that focus on personalized medicine. Her work aims to improve the accuracy and effectiveness of medication dosing for individual patients.
Latest Patents
Dellal's latest patents include innovative methods for smart multidosing. The first patent describes a method and algorithm for dosing single and multiple drugs for an individual patient. This method involves collecting data from the patient, including the drugs to be taken, the patient's age, medical condition, metabolism, and other relevant factors. The analysis of this data is conducted in light of dosing criteria established based on patient population data, ultimately recommending appropriate doses and alternative treatment options.
The second patent also focuses on smart multidosing, specifically for multiple drugs. This method collects data from the patient, including genetic testing information, and analyzes it against established dosing criteria derived from external patient data. A logic engine is employed to determine the appropriate doses for each drug, ensuring a tailored approach to medication management.
Career Highlights
Laura S. Dellal is currently associated with Optimdosing LLC, where she continues to develop her innovative ideas in drug dosing technology. Her work is pivotal in advancing personalized medicine, making significant strides in how medications are administered to patients.
Collaborations
Dellal collaborates with notable professionals in her field, including David Inwald and Kenneth I. Kohn. Their combined expertise contributes to the development of cutting-edge solutions in drug dosing.
Conclusion
Laura S. Dellal's contributions to drug dosing technology exemplify the impact of innovation in healthcare. Her patents reflect a commitment to improving patient outcomes through personalized medicine.